Search research articles
Contact Us
Filters
Showing results (221-230 of 269) with videos related to
Page
of 27
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 9, 2020
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)
Shamsah Kazani, David J Rowlands, Ivan Bottoli, et al.
The European Respiratory Journal
|
December 17, 2021
Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction
Niroop Kaza, Vivian Y Lin, Denise Stanford, et al.
American Journal of Respiratory Cell and Molecular Biology
|
September 2, 2016
The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke
S Vamsee Raju, Vivian Y Lin, Limbo Liu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 10, 2024
Glycemia and Insulin Secretion in Cystic Fibrosis Two Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO
Christine L Chan, Meghan Shirley Bezerra, Darko Stefanovski, et al.
JCI Insight
|
October 5, 2016
A ferret model of COPD-related chronic bronchitis
S Vamsee Raju, Hyunki Kim, Stephen A Byzek, et al.
The New England Journal of Medicine
|
November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
Bonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
Plos One
|
March 11, 2014
Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats
Katherine L Tuggle, Susan E Birket, Xiaoxia Cui, et al.
Biorxiv : the Preprint Server for Biology
|
July 1, 2024
Loss of cell junctional components and matrix alterations drive cell desquamation and fibrotic changes in Idiopathic Pulmonary Fibrosis
Rachana R Chandran, Preethi Vijayaraj, Rolando Garcia-Milian, et al.
The New England Journal of Medicine
|
May 19, 2015
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Claire E Wainwright, J Stuart Elborn, Bonnie W Ramsey, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 17, 2014
A functional anatomic defect of the cystic fibrosis airway
Susan E Birket, Kengyeh K Chu, Linbo Liu, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 269) with videos related to
Sort By:
Page
of 27
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 9, 2020
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)
Shamsah Kazani, David J Rowlands, Ivan Bottoli, et al.
The European Respiratory Journal
|
December 17, 2021
Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction
Niroop Kaza, Vivian Y Lin, Denise Stanford, et al.
American Journal of Respiratory Cell and Molecular Biology
|
September 2, 2016
The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke
S Vamsee Raju, Vivian Y Lin, Limbo Liu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 10, 2024
Glycemia and Insulin Secretion in Cystic Fibrosis Two Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO
Christine L Chan, Meghan Shirley Bezerra, Darko Stefanovski, et al.
JCI Insight
|
October 5, 2016
A ferret model of COPD-related chronic bronchitis
S Vamsee Raju, Hyunki Kim, Stephen A Byzek, et al.
The New England Journal of Medicine
|
November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
Bonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
Plos One
|
March 11, 2014
Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats
Katherine L Tuggle, Susan E Birket, Xiaoxia Cui, et al.
Biorxiv : the Preprint Server for Biology
|
July 1, 2024
Loss of cell junctional components and matrix alterations drive cell desquamation and fibrotic changes in Idiopathic Pulmonary Fibrosis
Rachana R Chandran, Preethi Vijayaraj, Rolando Garcia-Milian, et al.
The New England Journal of Medicine
|
May 19, 2015
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Claire E Wainwright, J Stuart Elborn, Bonnie W Ramsey, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 17, 2014
A functional anatomic defect of the cystic fibrosis airway
Susan E Birket, Kengyeh K Chu, Linbo Liu, et al.
Page
of 27